See more : CTP N.V. (CTPVF) Income Statement Analysis – Financial Results
Complete financial analysis of Transgene Biotek Limited (TRABI.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Transgene Biotek Limited, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Keiyo Co., Ltd. (8168.T) Income Statement Analysis – Financial Results
- Chiho Environmental Group Limited (0976.HK) Income Statement Analysis – Financial Results
- The Good Flour Corp. (GFCO.CN) Income Statement Analysis – Financial Results
- Arbor Metals Corp. (ABR.V) Income Statement Analysis – Financial Results
- WSM for Information Technology Co. (9595.SR) Income Statement Analysis – Financial Results
Transgene Biotek Limited (TRABI.BO)
About Transgene Biotek Limited
Transgene Biotek Ltd. is a biotechnology company, which manufactures and sells diagnostic kits. It involves in the production and oral formulation of different proteins using TrabiORAL technology. The firm's products portfolio includes TrabiDHA, Tacrolimus, and Orlistat. The company was founded by K. Koteswara Rao in 1991 and is headquartered in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.35M | 550.85K | 866.95K | 1.70M | 35.75K | 712.87K | 1.18M | 692.03K | 1.82M | 3.15M | 9.81M | 150.30M | 262.52M | 99.67M | 39.85M | 37.00M | 37.44M | 20.24M |
| Cost of Revenue | 4.04M | 663.16K | -462.13K | 608.28K | 147.88K | 338.53K | 487.10K | 182.72M | 7.50K | 212.49K | 2.40M | 142.46M | 220.21M | 51.87M | 8.02M | 5.21M | 6.52M | 3.46M |
| Gross Profit | -1.69M | -112.32K | 1.33M | 1.09M | -112.12K | 374.35K | 695.31K | -182.02M | 1.81M | 2.94M | 7.41M | 7.84M | 42.31M | 47.80M | 31.82M | 31.80M | 30.92M | 16.78M |
| Gross Profit Ratio | -72.03% | -20.39% | 153.31% | 64.12% | -313.59% | 52.51% | 58.80% | -26,303.04% | 99.59% | 93.25% | 75.51% | 5.22% | 16.12% | 47.96% | 79.87% | 85.93% | 82.59% | 82.91% |
| Research & Development | 0.00 | 48.51M | 0.00 | 0.00 | 263.36K | 0.00 | 6.00K | 96.97M | 0.00 | 761.50K | 213.44K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 352.81K |
| General & Administrative | 3.55M | 1.19M | 1.12M | 1.68M | 2.18M | 1.54M | 1.52M | 1.11M | 2.46M | 2.07M | 2.01M | 4.64M | 0.00 | 3.52M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 67.00K | 27.30K | 51.26K | 73.81K | 12.88K | 29.28K | 25.50K | 71.79K | 149.18K | 90.90K | 2.43M | 1.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.61M | 1.22M | 1.17M | 1.76M | 2.19M | 1.57M | 1.54M | 1.18M | 2.61M | 2.16M | 16.63M | 11.86M | 0.00 | 3.52M | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 1.75M | 371.44K | 915.10K | 34.94K | 885.73K | 42.99M | 4.82M | 1.68M | 180.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 5.40M | 53.74M | 103.43M | 103.64M | 105.70M | 103.58M | 102.60M | 180.82M | 218.14M | 190.81M | 189.83M | 25.59M | -135.13M | 35.38M | 18.77M | 18.80M | 16.23M | 3.11M |
| Cost & Expenses | 9.44M | 54.40M | 102.97M | 104.25M | 105.85M | 103.92M | 103.09M | 180.82M | 218.15M | 191.02M | 192.24M | 168.05M | 85.08M | 87.25M | 26.79M | 24.01M | 22.75M | 6.57M |
| Interest Income | 105.00K | 6.24M | 2.29M | 2.71M | 3.81M | 2.61M | 0.00 | 0.00 | 714.98K | 3.55M | 0.00 | 1.92M | 742.69K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.40M | 6.24M | 2.29M | 2.71M | 3.81M | 2.61M | 10.28M | 4.33M | 0.00 | 0.00 | 0.00 | 0.00 | 6.25M | 7.15M | 8.50M | 8.74M | 4.26M | 49.31K |
| Depreciation & Amortization | 923.00K | 49.50M | 99.24M | 99.08M | 98.97M | 98.94M | 98.91M | 175.27M | 205.02M | 171.81M | 172.16M | 10.15M | 3.77M | 3.52M | 6.70M | 6.96M | 6.38M | 5.90M |
| EBITDA | -4.34M | -8.77M | -2.51M | -2.60M | -6.85M | 13.54M | 52.69M | -19.03M | -9.63M | -15.95M | -1.16B | -9.59M | 181.22M | -83.74M | 16.40M | 16.47M | 17.88M | 19.56M |
| EBITDA Ratio | -184.72% | -789.64% | -286.70% | -150.78% | -19,145.09% | -576.92% | 3,281.02% | -5.47% | -531.32% | -506.45% | -104.73% | -6.38% | 69.03% | -84.02% | 49.58% | 53.92% | 56.28% | 96.68% |
| Operating Income | -7.09M | -60.03M | -103.88M | -104.35M | -107.61M | -105.78M | -119.95M | -200.88M | -215.38M | -191.35M | -1.33B | -20.34M | 171.94M | -87.25M | 13.06M | 12.99M | 14.69M | 13.67M |
| Operating Income Ratio | -301.79% | -10,897.07% | -11,981.96% | -6,154.64% | -300,960.40% | -14,838.33% | -10,144.69% | -29,028.03% | -11,864.37% | -6,079.27% | -13,597.71% | -13.54% | 65.49% | -87.54% | 32.76% | 35.11% | 39.24% | 67.53% |
| Total Other Income/Expenses | 534.00K | -4.48M | -165.64K | -1.80M | -2.02M | 15.28M | 63.44M | 2.25M | -731.03K | -3.66M | -1.16B | -2.60M | -1.00 | -18.47M | -8.50M | -8.74M | -4.26M | -49.31K |
| Income Before Tax | -6.56M | -60.09M | -104.02M | -104.35M | -109.62M | -87.93M | -56.52M | -198.61M | -215.38M | -191.35M | -1.33B | -20.34M | 171.94M | 1.68M | 4.56M | 4.26M | 10.43M | 13.62M |
| Income Before Tax Ratio | -279.05% | -10,907.93% | -11,998.40% | -6,154.34% | -306,601.70% | -12,334.25% | -4,780.45% | -28,699.24% | -11,864.37% | -6,079.27% | -13,597.71% | -13.54% | 65.49% | 1.68% | 11.44% | 11.50% | 27.86% | 67.29% |
| Income Tax Expense | 0.00 | 6.18M | 2.15M | 2.71M | 1.79M | 2.72M | 7.86M | 25.57M | 1.67M | 3.61M | 1.15B | 600.34K | 55.97M | 311.31K | 741.75K | 482.09K | 1.10M | 1.22M |
| Net Income | -6.56M | -60.09M | -104.02M | -104.35M | -109.62M | -87.93M | -64.39M | -198.61M | -215.38M | -191.35M | -1.33B | -20.34M | 115.96M | 1.37M | 3.82M | 3.77M | 9.33M | 12.40M |
| Net Income Ratio | -279.05% | -10,907.93% | -11,998.40% | -6,154.34% | -306,601.70% | -12,334.25% | -5,445.27% | -28,699.24% | -11,864.37% | -6,079.27% | -13,597.71% | -13.54% | 44.17% | 1.37% | 9.58% | 10.20% | 24.93% | 61.26% |
| EPS | -0.09 | -0.79 | -1.37 | -1.38 | -1.45 | -1.16 | -0.85 | -2.62 | -2.84 | -2.53 | -17.61 | -0.31 | 1.91 | 0.03 | 0.24 | 0.28 | 0.62 | 0.82 |
| EPS Diluted | -0.09 | -0.79 | -1.37 | -1.38 | -1.45 | -1.16 | -0.85 | -2.62 | -2.84 | -2.53 | -17.61 | -0.31 | 1.91 | 0.03 | 0.24 | 0.28 | 0.62 | 0.82 |
| Weighted Avg Shares Out | 72.83M | 75.77M | 75.77M | 75.77M | 75.77M | 75.77M | 75.75M | 75.77M | 75.77M | 75.63M | 75.77M | 65.63M | 65.77M | 40.77M | 15.77M | 15.33M | 15.02M | 15.02M |
| Weighted Avg Shares Out (Dil) | 72.83M | 75.77M | 75.77M | 75.77M | 75.77M | 75.77M | 75.77M | 75.77M | 75.77M | 75.77M | 75.77M | 65.77M | 65.77M | 40.77M | 15.77M | 15.33M | 15.02M | 15.02M |
No news found for: TRABI.BO
Source: https://incomestatements.info
Category: Stock Reports